Spread the love

Pharmaceutical company AstraZeneca on Tuesday said that it “voluntarily paused” the phase 3 clinical human trials of its vaccine candidate ‘Covishield’ after one of the volunteers got ill. AstraZeneca is developing this vaccine in collaboration with University of Oxford.

The suspension of the trial has impacted other AstraZeneca vaccine trials – as well as clinical trials being conducted by other vaccine makers, which are looking for signs of similar reactions, Stat said.

AstraZeneca’s statement said that “in large trials, illnesses will happen by chance but must be independently reviewed to check this carefully.”


Leave comment

Your email address will not be published. Required fields are marked with *.